ReSTORE - A phase 3 study of the efficacy and safety of rezafungin for injection versus intravenous caspofungin followed by optional oral fluconazole step-down in the treatment of subjects with candidemia and/or invasive candidiasis

Administered By

Awarded By

Contributors

Start/End

  • January 23, 2019 - March 7, 2022